MEDSUD: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDSUD
Largest movements
- Stocks and contracts -€6,145
no longer reported in 2025 (was €6,145)
- Cash +€1,795
up €1,795 (+279.4%), from €642 to €2,437
mainly Other debts (+€20,242) and Stocks and contracts (+€6,145)
- Receivables within one year +€1,349
new in 2025: €1,349
- Intangible fixed assets -€600
down €600 (-50.0%), from €1,200 to €600
- Tangible fixed assets +€355
new in 2025: €355
- Profit (loss) carried forward -€23,477
down €23,477 (-33.1%), from -€70,829 to -€94,306
- Other debts +€20,242
up €20,242 (+28.1%), from €71,949 to €92,191
- Gross operating margin -€19,087
down €19,087, from €6,752 to -€12,335
- Financial charges +€8,473
up €8,473 (+2450.3%), from €346 to €8,818
- Other operating charges -€2,986
down €2,986 (-63.7%), from €4,685 to €1,699
- Depreciation -€125
down €125 (-16.7%), from €750 to €625
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,088 | €4,841 | -€3,247 | -40.1% |
| Fixed assets | 21/28 | €1,300 | €1,055 | -€245 | -18.8% |
| Intangible fixed assets | 21 | €1,200 | €600 | -€600 | -50.0% |
| Tangible fixed assets | 22/27 | - | €355 | +€355 | |
| Furniture and vehicles | 24 | - | €355 | +€355 | |
| Financial fixed assets | 28 | €100 | €100 | = | 0.0% |
| Current assets | 29/58 | €6,788 | €3,786 | -€3,002 | -44.2% |
| Stocks and contracts in progress | 3 | €6,145 | - | -€6,145 | |
| Stocks | 30/36 | €6,145 | - | -€6,145 | |
| Amounts receivable within one year | 40/41 | - | €1,349 | +€1,349 | |
| Other amounts receivable | 41 | - | €1,349 | +€1,349 | |
| Cash at bank and in hand | 54/58 | €642 | €2,437 | +€1,795 | +279.4% |
| Total equity and liabilities | 10/49 | €8,088 | €4,841 | -€3,247 | -40.1% |
| Equity | 10/15 | -€64,265 | -€87,742 | -€23,477 | -36.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €364 | €364 | = | 0.0% |
| Non-distributable reserves | 130/1 | €364 | €364 | = | 0.0% |
| Reserves not available under the articles | 1311 | €364 | €364 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€70,829 | -€94,306 | -€23,477 | -33.1% |
| Amounts payable | 17/49 | €72,353 | €92,583 | +€20,231 | +28.0% |
| Amounts payable within one year | 42/48 | €72,353 | €92,583 | +€20,231 | +28.0% |
| Taxes, remuneration and social security | 45 | €404 | €392 | -€11 | -2.8% |
| Taxes | 450/3 | €404 | €392 | -€11 | -2.8% |
| Other amounts payable | 47/48 | €71,949 | €92,191 | +€20,242 | +28.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €750 | €625 | -€125 | -16.7% |
| Other operating charges | 640/8 | €4,685 | €1,699 | -€2,986 | -63.7% |
| Gross operating margin | 9900 | €6,752 | -€12,335 | -€19,087 | |
| Operating profit (loss) | 9901 | €1,317 | -€14,659 | -€15,976 | |
| Financial income | 75/76B | €1 | €0 | -€1 | -69.8% |
| Recurring financial income | 75 | €1 | €0 | -€1 | -69.8% |
| Financial charges | 65/66B | €346 | €8,818 | +€8,473 | +2450.3% |
| Recurring financial charges | 65 | €346 | €8,818 | +€8,473 | +2450.3% |
| Profit (loss) for the period before taxes | 9903 | €972 | -€23,477 | -€24,449 | |
| Profit (loss) for the period | 9904 | €972 | -€23,477 | -€24,449 | |
| Profit (loss) for the period to be appropriated | 9905 | €972 | -€23,477 | -€24,449 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.